New cash-paying patients can now access Wegovy/Ozempic for $199 a month. Here's what that means for Novo Nordisk stock.
The “Before” and “After” photos are breaking the internet. Facebook groups, Reddit threads and gobs of other social media ...
Savile Row boss says weight loss drugs having ‘massive repercussions’ on industry - Among GLP-1 users, more than half said ...
Eli Lilly is well on its way to the trillion-dollar club. The stock price is up 30% so far this year; with a total ...
Wegovy’s key competitor is Eli Lilly’s GLP-1 drug Mounjaro (tirzepatide), which became India’s top-selling medicine in ...
Danish pharma major Novo Nordisk has slashed the price of Wegovy by up to 37%, to take on its key rival Eli Lilly. Here's how ...
Danish drugmaker Novo Nordisk on Tuesday announced slashing prices of its weight-loss drug Wegovy by up to 37 per cent in a ...
Shares of Amgen are up nearly 26% this year and have soared 11% just over the past week.
The starting dose of 0.25 mg will now cost Rs 2,712 per week, down from Rs 4,336 earlier, with the new prices effective ...
Equity markets delivered a mixed response after Pfizer won the bidding war for anti-obesity drugmaker Metsera, as Metsera’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback